Global tuberculosis report 2019. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO. https://apps.who.int/iris/bitstream/handle/10665/329368/9789241565714-eng.pdf?ua=1 (Accessed 23 July 2020).
World Health Organization. Global tuberculosis report 2013. Geneva: World Health Organization; 2013. https://apps.who.int/iris/handle/10665/91355 (Accessed 23 July 2020).
Google Scholar
TB CARE I. International standards for tuberculosis care. 3rd ed. The Hague: TB CARE I; 2014. https://www.who.int/tb/publications/ISTC_3rdEd.pdf?ua=1 (Accessed 23 July 2020).
Google Scholar
Mekonnen D, Derbie A, Desalegn E. TB/HIV co-infections and associated factors among patients on directly observed treatment short course in Northeastern Ethiopia: a 4 years retrospective study. BMC Res Notes. 2015;8:666.
PubMed
PubMed Central
Google Scholar
Tweya H, Feldacker C, Phiri S, et al. Comparison of treatment outcomes of new smear-positive pulmonary tuberculosis patients by HIV and antiretroviral status in a TB/HIV clinic, Malawi. PLoS ONE. 2013;8:e56248.
CAS
PubMed
PubMed Central
Google Scholar
Rifat M, Hall J, Oldmeadow C, Husain A, Hinderaker SG, Milton AH. Factors related to previous tuberculosis treatment of patients with multidrug-resistant tuberculosis in Bangladesh. BMJ Open. 2015;5:e008273.
PubMed
PubMed Central
Google Scholar
Dolin PJ, Raviglione MC, Kochi A. Global tuberculosis incidence and mortality during 1990–2000. Bull World Health Organ. 1994;72:213–20.
CAS
PubMed
PubMed Central
Google Scholar
Kyu HH, Maddison ER, Henry NJ, et al. The global burden of tuberculosis: results from the Global Burden of Disease Study 2015. Lancet Infect Dis. 2018;18:261–84.
Google Scholar
Aaron L, Saadoun D, Calatroni I, et al. Tuberculosis in HIV-infected patients: a comprehensive review. Clin Microbiol Infect. 2004;10:388–98.
CAS
PubMed
Google Scholar
Singh A, Prasad R, Balasubramanian V, Gupta N. Drug-resistant tuberculosis and HIV infection: current perspectives. HIV AIDS. 2020;12:9–31. https://doi.org/10.2147/HIV.S193059.
Article
CAS
Google Scholar
Knight GM, McQuaid CF, Dodd PJ, Houben RMGJ. Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling. Lancet Infect Dis. 2019;19:903–12.
PubMed
PubMed Central
Google Scholar
Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003;163:1009–21.
PubMed
Google Scholar
Sharma P, Lalwani J, Pandey P, Thakur A. Factors associated with the development of secondary multidrug-resistant tuberculosis. Int J Prev Med. 2019;10:67.
PubMed
PubMed Central
Google Scholar
Khan PY, Yates TA, Osman M, et al. Transmission of drug-resistant tuberculosis in HIV-endemic settings. Lancet Infect Dis. 2019;19:e77–88.
PubMed
Google Scholar
Suchindran S, Brouwer ES, Van Rie A. Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic review. PLoS ONE. 2009;4:e5561.
PubMed
PubMed Central
Google Scholar
Mesfin YM, Hailemariam D, Biadgilign S, Biadglign S, Kibret KT. Association between HIV/AIDS and multi-drug resistance tuberculosis: a systematic review and meta-analysis. PLoS ONE. 2014;9:e82235.
PubMed
PubMed Central
Google Scholar
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
PubMed
PubMed Central
Google Scholar
Brito RC, Mello FCQ, Andrade MK, et al. Drug-resistant tuberculosis in six hospitals in Rio de Janeiro, Brazil. Int J Tuberc Lung Dis. 2010;14:24–33.
CAS
PubMed
Google Scholar
Andrews JR, Shah NS, Weissman D, Moll AP, Friedland G, Gandhi NR. Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community. PLoS ONE. 2010;5:e15735.
CAS
PubMed
PubMed Central
Google Scholar
Sangaré L, Diandé S, Badoum G, Dingtoumda B, Traoré AS. Anti-tuberculosis drug resistance in new and previously treated pulmonary tuberculosis cases in Burkina Faso. Int J Tuberc Lung Dis. 2010;14:1424–9.
PubMed
Google Scholar
Sangaré L, Diandé S, Ouédraogo G, Traoré AS. HIV infection and Mycobacterium tuberculosis drug-resistance among tuberculosis patients in Burkina Faso, West Africa. Afr J Clin Exp Microbiol. 2011;12(1). https://doi.org/10.4314/ajcem.v12i1.61047.
Gudo PS, Cuna Z, Coelho E, et al. Is multidrug-resistant tuberculosis on the rise in Mozambique? Results of a national drug resistance survey. Eur Respir J. 2011;38:222–4.
Google Scholar
Vadwai V, Shetty A, Soman RN, Rodrigues CC. Determination of risk factors for isoniazid monoresistance and multidrug-resistant tuberculosis in treatment failure patients. Scand J Infect Dis. 2012;44:48–50.
CAS
PubMed
Google Scholar
Macedo R, Antunes AF, Villar M, Portugal I. Multidrug and extensively drug-resistant tuberculosis in Lisbon and Vale do Tejo, Portugal, from 2008 to 2010. Int J Mycobacteriol. 2012;1:131–6.
CAS
PubMed
Google Scholar
Sanchez-Padilla E, Dlamini T, Ascorra A, et al. High prevalence of multidrug-resistant tuberculosis, Swaziland, 2009–2010. Emerg Infect Dis. 2012;18:29–37.
PubMed
PubMed Central
Google Scholar
van Halsema CL, Fielding KL, Chihota VN, Lewis JJ, Churchyard GJ, Grant AD. Trends in drug-resistant tuberculosis in a gold-mining workforce in South Africa, 2002–2008. Int J Tuberc Lung Dis. 2012;16:967–73.
PubMed
Google Scholar
Ricks PM, Mavhunga F, Modi S, et al. Characteristics of multidrug-resistant tuberculosis in Namibia. BMC Infect Dis. 2012;12:385.
PubMed
PubMed Central
Google Scholar
Tessema B, Beer J, Emmrich F, Sack U, Rodloff AC. First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia. Int J Tuberc Lung Dis. 2012;16:805–11.
CAS
PubMed
Google Scholar
Coelho AGV, Zamarioli LA, Telles MA, Ferrazoli L, Waldman EA. A study of multidrug-resistant tuberculosis in risk groups in the city of Santos, São Paulo, Brazil. Mem Inst Oswaldo Cruz. 2012;107:760–6.
CAS
PubMed
Google Scholar
Ulmasova DJ, Uzakova G, Tillyashayhov MN, Turaev L, van Gemert W, Hoffmann H, Zignol M, Kremer K, Gombogaram T, Gadoev J, du Cros P, Muslimova N, Jalolov A, Dadu A, de Colombani P, Telnov O, Slizkiy A, Kholikulov B, Dara M, Falzon D. Multidrug-resistant tuberculosis in Uzbekistan:results of a nationwide survey, 2010 to 2011. Euro Surveill. 2013;18(42):20609. https://doi.org/10.2807/1560-7917.es2013.18.42.20609. PMID: 24176581.
Minion J, Gallant V, Wolfe J, Jamieson F, Long R. Multidrug and extensively drug-resistant tuberculosis in Canada 1997–2008: demographic and disease characteristics. PLoS ONE. 2013;8:e53466.
CAS
PubMed
PubMed Central
Google Scholar
Sethi S, Mewara A, Dhatwalia SK, et al. Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India. BMC Infect Dis. 2013;13:137.
PubMed
PubMed Central
Google Scholar
van den Hof S, Tursynbayeva A, Abildaev T, et al. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan. Int J Tuberc Lung Dis. 2013;17:526–31.
PubMed
Google Scholar
Lukoye D, Adatu F, Musisi K, Kasule GW, Were W, Odeke R, Kalamya JN, Awor A, Date A, Joloba ML. Anti-tuberculosis drug resistance among new and previously treated sputum smear-positive tuberculosis patients in Uganda: results of the first national survey. PLoS One. 2013;8(8):e70763. https://doi.org/10.1371/journal.pone.0070763. PMID: 23936467; PMCID: PMC3731251.
Hang NT, Maeda S, Lien LT, Thuong PH, Hung NV, Thuy TB, Nanri A, Mizoue T, Hoang NP, Cuong VC, Ngoc KT, Sakurada S, Endo H, Keicho N. Primary drug-resistant tuberculosis in Hanoi, Viet Nam: present status and risk factors. PLoS One. 2013;8(8):e71867. https://doi.org/10.1371/journal.pone.0071867. PMID: 23967255; PMCID: PMC3742467.
Skrahina A, Hurevich H, Zalutskaya A, et al. Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factors. Bull World Health Organ. 2013;91:36–45.
PubMed
Google Scholar
Satti H, McLaughlin MM, Seung KJ, Becerra MC, Keshavjee S. High risk of drug-resistant tuberculosis when first-line therapy fails in a high HIV prevalence setting. Int J Tuberc Lung Dis. 2013;17:100–6.
CAS
PubMed
Google Scholar
Hirpa S, Medhin G, Girma B, et al. Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa: a case control study. BMC Public Health. 2013;13:782.
PubMed
PubMed Central
Google Scholar
Mor Z, Goldblatt D, Kaidar-Shwartz H, Cedar N, Rorman E, Chemtob D. Drug-resistant tuberculosis in Israel: risk factors and treatment outcomes. Int J Tuberc Lung Dis. 2014;18:1195–201.
CAS
PubMed
Google Scholar
Post FA, Grint D, Werlinrud AM, et al. Multi-drug-resistant tuberculosis in HIV positive patients in Eastern Europe. J Infect. 2014;68:259–63.
PubMed
Google Scholar
Metcalfe JZ, Makumbirofa S, Makamure B, et al. Drug-resistant tuberculosis in high-risk groups, Zimbabwe. Emerg Infect Dis. 2014;20:135–7.
PubMed
PubMed Central
Google Scholar
Mohd Shariff N, Shah SA, Kamaludin F. Previous treatment, sputum-smear nonconversion, and suburban living: the risk factors of multidrug-resistant tuberculosis among Malaysians. Int J Mycobacteriol. 2016;5:51–8.
PubMed
Google Scholar
Jitmuang A, Munjit P, Foongladda S. Prevalence and factors associated with multidrug-resistant tuberculosis at Siriraj Hospital, Bangkok, Thailand. Southeast Asian J Trop Med Public Health. 2015;46(4):697–706 PMID: 26867390.
PubMed
Google Scholar
Chuchottaworn C, Thanachartwet V, Sangsayunh P, Than TZ, Sahassananda D, Surabotsophon M, Desakorn V. Risk Factors for Multidrug-Resistant Tuberculosis among Patients with Pulmonary Tuberculosis at the Central Chest Institute of Thailand. PLoS One. 2015;10(10):e0139986. https://doi.org/10.1371/journal.pone.0139986. PMID: 26444421; PMCID: PMC4596622.
Elmi OS, Hasan H, Abdullah S, Mat Jeab MZ, Bin Alwi Z, Naing NN. Multidrug-resistant tuberculosis and risk factors associated with its development: a retrospective study. J Infect Dev Ctries. 2015;9:1076–85.
CAS
PubMed
Google Scholar
Mulisa G, Workneh T, Hordofa N, Suaudi M, Abebe G, Jarso G. Multidrug-resistant Mycobacterium tuberculosis and associated risk factors in Oromia Region of Ethiopia. Int J Infect Dis. 2015;39:57–61.
PubMed
Google Scholar
Mulu W, Mekonnen D, Yimer M, Admassu A, Abera B. Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State. Afr Health Sci. 2015;15:368–77.
PubMed
PubMed Central
Google Scholar
Günther G, van Leth F, Alexandru S, et al. Multidrug-resistant tuberculosis in Europe, 2010–2011. Emerg Infect Dis. 2015;21:409–16.
PubMed
PubMed Central
Google Scholar
Ershova JV, Volchenkov GV, Kaminski DA, et al. Epidemiology of primary multidrug-resistant tuberculosis, Vladimir Region, Russia. Emerg Infect Dis. 2015;21:2048–51.
PubMed
PubMed Central
Google Scholar
Abdella K, Abdissa K, Kebede W, Abebe G. Drug resistance patterns of Mycobacterium tuberculosis complex and associated factors among retreatment cases around Jimma, Southwest Ethiopia. BMC Public Health. 2015;15:599.
PubMed
PubMed Central
Google Scholar
Tadesse F. Risk factors for multi-drug resistant tuberculosis in Addis Ababa, Ethiopia; 2015.
Google Scholar
Salindri AD, Kipiani M, Kempker RR, et al. Diabetes reduces the rate of sputum culture conversion in patients with newly diagnosed multidrug-resistant tuberculosis. Open Forum Infect Dis. 2016;3:ofw126.
PubMed
PubMed Central
Google Scholar
Lee S, Lee SH, Mok JH, et al. Is Multi-drug resistant tuberculosis more prevalent in HIV-infected patients in Korea? Yonsei Med J. 2016;57:1508–10.
PubMed
PubMed Central
Google Scholar
Assefa D, Seyoum B, Oljira L. Determinants of multidrug-resistant tuberculosis in Addis Ababa, Ethiopia. Infect Drug Resist. 2017;10:209–13.
PubMed
PubMed Central
Google Scholar
Workicho A, Kassahun W, Alemseged F. Risk factors for multidrug-resistant tuberculosis among tuberculosis patients: a case-control study. Infect Drug Resist. 2017;10:91–6.
PubMed
PubMed Central
Google Scholar
Sinha P, Srivastava GN, Gupta A, Anupurba S. Association of Risk Factors and Drug Resistance Pattern in Tuberculosis Patients in North India. J Global Infect Dis. 2017;9:139–45.
CAS
Google Scholar
Mesfin EA, Beyene D, Tesfaye A, et al. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia. PLoS ONE. 2018;13:e0197737.
PubMed
PubMed Central
Google Scholar
Gobena D, Ameya G, Haile K, Abreha G, Worku Y, Debela T. Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study. Ann Clin Microbiol Antimicrob. 2018;17:30.
PubMed
PubMed Central
Google Scholar
Kusumawati RL, Tania T, Mcneil E, Chongsuvivatwong V. Predictors of multidrug resistance among pulmonary tuberculosis patients in a tertiary Hospital in North Sumatera, Indonesia; 2018. https://doi.org/10.15562/bmj.v7i1.813.
Book
Google Scholar
Pavlenko E, Barbova A, Hovhannesyan A, et al. Alarming levels of multidrug-resistant tuberculosis in Ukraine: results from the first national survey. Int J Tuberc Lung Dis. 2018;22:197–205.
CAS
PubMed
Google Scholar
Desissa F, Workineh T, Beyene T. Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia. BMC Public Health. 2018;18:422.
PubMed
PubMed Central
Google Scholar
Gaborit BJ, Revest M, Roblot F, et al. Characteristics and outcome of multidrug-resistant tuberculosis in a low-incidence area. Med Mal Infect. 2018;48:457–64.
CAS
PubMed
Google Scholar
Alene KA, Viney K, McBryde ES, Gray DJ, Melku M, Clements ACA. Risk factors for multidrug-resistant tuberculosis in northwest Ethiopia: a case-control study. Transbound Emerg Dis. 2019;66:1611–8.
CAS
PubMed
Google Scholar
Baya B, Achenbach CJ, Kone B, et al. Clinical risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in Mali. Int J Infect Dis. 2019;81:149–55.
PubMed
PubMed Central
Google Scholar
Zürcher K, Ballif M, Fenner L, et al. Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study. Lancet Infect Dis. 2019;19:298–307.
PubMed
PubMed Central
Google Scholar
Okethwangu D, Birungi D, Biribawa C, et al. Multidrug-resistant tuberculosis outbreak associated with poor treatment adherence and delayed treatment: Arua District, Uganda, 2013–2017. BMC Infect Dis. 2019;19:387.
PubMed
PubMed Central
Google Scholar
Fikre A, Tewelde T, Shaweno T. Determinants of multi-drug resistant tuberculosis among tuberculosis patients in Southern Ethiopia: a case control study. J Med Bacteriol. 2019;8:1–12.
Google Scholar
Elduma AH, Mansournia MA, Foroushani AR, et al. Assessment of the risk factors associated with multidrug-resistant tuberculosis in Sudan: a case-control study. Epidemiol Health. 2019;41:e2019014.
PubMed
PubMed Central
Google Scholar
Chen MP, Miramontes R, Kammerer JS. Multidrug-resistant tuberculosis in the United States, 2011–2016: patient characteristics and risk factors. Int J Tuberc Lung Dis. 2020;24(1):92–9. https://doi.org/10.5588/ijtld.19.0173.
Article
CAS
PubMed
Google Scholar
Arroyo LH, Yamamura M, Ramos ACV, et al. Determinants of multidrug-resistant tuberculosis in São Paulo-Brazil: a multilevel Bayesian analysis of factors associated with individual, community and access to health services. Tropical Med Int Health. 2020;25(7):839–49. https://doi.org/10.1111/tmi.13409.
Article
Google Scholar
Hirama T, Sabur N, Derkach P, et al. Risk factors for drug-resistant tuberculosis at a referral centre in Toronto, Ontario, Canada: 2010–2016. Can Commun Dis Rep. 2020;46(4):84–92. Published 2020 Apr 2. https://doi.org/10.14745/ccdr.v46i04a05.
Article
PubMed
PubMed Central
Google Scholar
World Bank Country and Lending Groups – World Bank data help desk. https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups (Accessed 23 Oct 2019).
Kendall EA, Fofana MO, Dowdy DW. The burden of transmitted multi-drug resistance among epidemics of tuberculosis: a transmission model. Lancet Respir Med. 2015;3:963–72.
PubMed
PubMed Central
Google Scholar
Chen Y, Yuan Z, Shen X, Wu J, Wu Z, Xu B. Time to multidrug-resistant tuberculosis treatment initiation in association with treatment outcomes in Shanghai, China. Antimicrob Agents Chemother. 2018;62:e02259.
CAS
PubMed
PubMed Central
Google Scholar
Oni T, Burke R, Tsekela R, et al. High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening. Thorax. 2011;66:669–73.
PubMed
Google Scholar
Kwan CK, Ernst JDHIV. Tuberculosis: a deadly human syndemic. Clin Microbiol Rev. 2011;24:351–76. https://doi.org/10.1128/CMR.00042-10.
Article
PubMed
PubMed Central
Google Scholar
El-Sadr WM, Tsiouris SJ. HIV-associated tuberculosis: diagnostic and treatment challenges. Semin Respir Crit Care Med. 2008;29:525–31.
PubMed
Google Scholar
van Rie A, Victor TC, Richardson M, et al. Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns. Am J Respir Crit Care Med. 2005;172:636–42.
PubMed
PubMed Central
Google Scholar
Hanekom M, Streicher EM, de Berg DV, et al. Population structure of mixed Mycobacterium tuberculosis infection is strain genotype and culture medium dependent. PLoS ONE. 2013;8:e70178.
CAS
PubMed
PubMed Central
Google Scholar
Cohen T, Chindelevitch L, Misra R, et al. Within-host heterogeneity of Mycobacterium tuberculosis infection is associated with poor early treatment response: a prospective cohort study. J Infect Dis. 2016;213:1796–9.
PubMed
PubMed Central
Google Scholar
Makhado NA, Matabane E, Faccin M, et al. Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study. Lancet Infect Dis. 2018;18:1350–9.
PubMed
Google Scholar